News | Site Map | E-reporting
  Home Corporate Profile Business Divisions Products Careers Contacts Feedback
    

 

    Dear Shareholders,

    It gives me great pleasure to inform you that the Company has successfully concluded Financial Year 2005-06 by     achieving turnover of over Rs.150 cr and net profit of Rs.9.68 cr. It is rather unfortunate thatwe are unable to     meet personally and therefore I would like to share some of the important achievements of the Company in the     recent past and the future plans.At the Annual General Meeting I have briefed the Members present about the     developments which took place in your Company during the last year. I would like to take this opportunity to     summarize the same for you.

    POST MERGER
    After Amalgamation of your Company with CareUnipac Pvt. Ltd., the accumulated losses of theCompany has been     wiped out and now the networth of your Company is positive.

    SYNERGY IN OPERATIONS
    Your Company has reached an arrangement withTwilight Mercantiles Ltd. Mumbai based Pharma Company for joint     marketing of each others' products in each others' territories. Your Company will enjoy the benefits of synergy     since marketing efforts will get a big boost with increase in the marketing strength Synergy - Marketing staff of both     Companies have already started promoting each others' products in extended geographical areas

    The End Results would be:
     Newer products and newer territories
     Export potential in over 40 Countries.
     600 StrongFieldForce and servicing one lac Doctors.
     Better distribution (1000 stockists will ensure availability
     Strong presence throughout India.
     Strong financial resource base.

    To take advantage of marketing infra-structure, it was decided to change the name of the Company as TWILIGHT     LITAKA PHARMA LIMITED. The Members have in the Extra Ordinary General Meeting held on 17th June, 2006     accorded their approval to the said change. Subsequently, theRegistrar of Companies accorded their approval and     with effect from 4th July, 2006 the name of the Company has been changed from LiTaka Pharmaceuticals Ltd., to     TWILIGHT LITAKA PHARMA LIMITED.

    CHANGE IN SHARE CAPITAL
    In pursuance of the Scheme of Amalgamation, your Company was required to allot 11,72,32,500 Equity Shares to     the Shareholders of Care Unipac Pvt. Ltd. Hence the authorized Share Capital was increased from     Rs.20,00,00,000/- to Rs.21,50,00,000/-. After the completion of all the relevant formalities the Directors of your     Company, on 22nd June, 2006 allotted 11,72,32,500 Equity Shares to the Shareholders of Care Unipac Pvt. Ltd.     Subsequent to this allotment, the Paid-up Share Capital has been increased from Rs.9,54,87,850/- to     Rs.21,28,12,850/-.

    REDUCTION IN SHARE CAPITAL
    The Members are also aware that in the Extra Ordinary General Meeting held on 4 March, 2006, the Shareholders     have accorded their consent for reduction of Share Capital by reducing the face value from Rs.10/- to Rs.5/-. Your     Company has already filedPetition in the Hon'ble BombayHigh Court, for its approval to the said Scheme of     Reduction of Share Capital. ThePetition is at a final stage and we expect that the Court will approve the said     Scheme shortly. After the approval is received and the necessary listing formalities are completed, the Company will     give effect to the capital reduction scheme and thereafter the paid-up equity capital of your Company will stand     reduced to Rs.10,64,06,425 divided into 2,12,81,285 Equity Shares of Rs.5/- each fully paid.

    PERFORMANCE OF THE COMPANY
    From the Annual Report for the Financial Year 2005-06, you must have noticed that Company's overall performance     has improved. The turnover of your Company increased to Rs.157 cr and the Company has earned Profit after Tax     of Rs.9.68 cr. Registration of products in export markets in about 40 countries has started materializing which has     given a big boost to the export turnover. The direct exports have increased from Rs.3 cr to Rs.8 cr in 05-06 and     are expected to reach Rs.18 cr in the current year. Your Company's arrangement of marketing operations with     Twilight Mercantiles Ltd., growth in Contract Manufacturing and sourcing of Export Orders has reaped rich dividend.     It is expected that your Company will grow at over 40% in the current Financial Year in all segments, namely,     Contract Manufacturing, Domestic and Exports.

    ENHANCEMENT IN THE MANUFACTURING CAPACITY
    You are aware that at present your Company is having threeWHO-GMPapproved manufacturing facilities in     Maharashtra with adequate capacities to achieve Rs.500 cr turnover. In addition to this Twilight Group is setting up     one more manufacturing unit at Himachal Pradesh which will be dedicated for the manufacturing operations of your     Company. Your Company will enjoy huge benefits due to excise exemptions after the production commences at     Baddi, Himachal Pradesh.

    FIRST QUARTER UNAUDITED FINANCIAL RESULTS
    First Quarter unaudited Financial Results of the current fiscal has been very encouraging. The Company achieved     turnover of over Rs.42 cr and has earned a net profit of Rs.2.89 cr. The Management is confident that the     Company will maintain the same pace of growth throughout the year. Now your Company has wiped out all     accumulated losses and as such as per the Company Law provisions, your Company is entitled to declare dividend.     Accordingly, your Company may enter on the list of dividend paying companies after its financial position is     consolidated.

    IMPROVED EARNING PER SHARE
    As on 31.03.2006 on the basis of increased paid up capital, the basic and diluted EPS, of Rs.10/- is Rs.4.49 as     compared to Rs.0.79 as on 31.03.2005. It is to be noted that after giving effect to the Scheme of Reduction of     Share Capital EPS will be Rs.10.01. In conclusion I can assure you that the potential of your Company is extremely     good. Amalgamation and Reduction of Share Capital have improved the net worth of the Company and have wiped     out the accumulated losses. The marketing arrangement with Twilight Group will have long term positive impact on     the overall performance.Your Company, after merger, is ranked in the top 100 in the Country's pharmaceutical     formulations market. I am confident with continued excellence in performance, your company will position itself     amongst the first 50 pharma companies within next couple of years.
    I express my sincere thanks to you for the support extended to the Management, particularly when the Company     was passing through rough weather. I am thankful to all of you for the patience you have shown and for the belief     in us. I am sure that this will pay rich dividend in the future.

    With warm regards,

    GOPAL RAMOURTI
    Chairman of theA.G.M.
    held on 3 August, 2006
 
Home | Corporate Profile | Business Divisions | Products | Careers | Contacts | Feedback
Copyright © Twilight Litaka Pharma Ltd.